AnalystsDev PrasadDev Prasad's Stock Forecasts
AnalystsDev Prasad
Sectors:
Industries:
Analyst Ranking
Top 31%
#1591 out of 5290 analysts
Average Return
+93.98%
Win Rate
67%4 out of 6
Risk vs Reward
Poor
Good
Dev Prasad's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Opus Genetics IncIRD | +402.16% | $0.92 | $4.64 | 2025-06-16 - 2026-06-04 | Strong Buy |
Avalo Therapeutics IncAVTX | +100.64% | $9.38 | $18.82 | 2024-12-16 - 2025-12-16 | Strong Buy |
Calcimedica IncCALC | +87.77% | $2.78 | $5.22 | 2024-12-16 - 2025-12-16 | Strong Buy |
Cue Biopharma IncCUE | +20.75% | $24.55 | $29.64 | 2025-08-24 - 2026-06-04 | Strong Buy |
Dev Prasad Analyst Color
Get additional color on Dev Prasad's coverage of popular stocks
Dev Prasad's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Quoin Pharmaceuticals LtdQNRX | 1 | Strong Buy | $30.00 | +599.30% | Initiates Coverage On | a month ago |
Atyr Pharma IncATYR | 1 | Hold | $1.00 | +94.93% | Downgrades | 9 months ago |
Cue Biopharma IncCUE | 1 | Strong Buy | $120.00 | +304.86% | Initiates Coverage On | 9 months ago |
Opus Genetics IncIRD | 1 | Strong Buy | $5.00 | +7.76% | Initiates Coverage On | a year ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | a year ago |
Ibio IncIBIO | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | a year ago |
Calcimedica IncCALC | 1 | Strong Buy | $13.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.